Figure 4From: A health economic model for evaluating a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in the UK Probabilistic Sensitivity Analysis - NHS Perspective: Scatter Plot of ICERs and Cost-Effectiveness Acceptability Curve. Note: The points in the 4th quadrant of the scatter plot represent negative incremental outcomes, as during some of the PSA runs the vaccination policy will result in lower outcomes than the no vaccination policy.Back to article page